This page contains a Flash digital edition of a book.
»


MANUFACTURING


»


How Clean is Clean in Drug Manufacturing? Part 2


Igor Gorsky Sr. Consultant, ConcordiaValsource, LLC


Introduction


This article is the second part of an article titled, “How Clean is Clean in Drug Manufacturing?” The first article reminded practitioners that Cleaning is an official process, and introduced the term Equipment Cleaning Process (ECP) which will be used in this part as well. In addition, that article described tools that may aid practitioners in the establishment of appropriate residual limits. This article will present a number of tools that may be utilized for the measurement of ECP during all 3 stages of its continuum:


• Development of Cleaning Procedures by Research and Development groups (if it exists)


• Validation of Cleaning Procedures by Technical or Quality groups


• Application of Cleaning Processes by Operations/ Manufacturing organizations.


Submitted: 11/17/2014 Accepted for Publication: 12/01/2014


Gorsky I. How clean is clean in drug manufacturing? Part 2. Am Pharm Rev. 2015;18(1):24-35.


The key to control for any process resides in the understanding of its variability. How much do we know about the variation of our processes or systems and are we in the state of control? These questions require answers to achieve success in the execution of ECP. Understanding, detection, response, and control, from input through output of variation, consumed a focus of the revised FDA Process Validation Guidance1


to Industry (Figure 1).2,3


Stage 1: ECP Design and Development To be highly effective, a Risk


So how does one go about control of variation? To do that one has to enable a Risk Management System.2


Management System needs to be initiated early on during the design and development of ECP. A rigorous application of Risk Management tools during Stage 1 (Process Design Stage) will help the practitioner to assess, understand, and ultimately control the level of variation in systems and processes. Therefore, Critical Quality Attributes and


24 | | January/February 2015


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76